Or. Admin. R. 333-116-0220

Current through Register Vol. 63, No. 8, August 1, 2024

Section 333-116-0220 - Labeling of Vials and Syringes

Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radiopharmaceutical drug. Each syringe shield and vial shield must also be labeled unless the label on the syringe or vial is visible when shielded. The label must include the radiopharmaceutical name or abbreviation, the type of diagnostic study or therapy procedure to be performed and the patient's name.

HD 1-1991, f. & cert. ef. 1-8-91; PH 12-2006, f. & cert. ef. 6-16-06; PH 4-2007, f. & cert. ef. 3-1-07; PH 10-2011, f. 9-30-11, cert. ef. 10-1-11; PH 12-2018, minor correction filed 01/30/2018, effective 1/30/2018

Statutory/Other Authority: ORS 453.635

Statutes/Other Implemented: ORS 453.605 - 453.807